Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atracurium regional intravenous injection to improve muscle relaxation during knee arthroscopy under peripheral nerve block
ACTRN12616001357448Phase 4Not yet recruiting
- Sponsor
- Dr. Irfan Gungor
- Start
- Oct 2016
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial comparing Atracurium isolated limb injection with Placebo saline injection (2 arms). Primary endpoint: Proportion of participants with at least 50% reduction in MEP amplitude after study injection. Planned start Oct 2016; status: not yet recruiting.
02
Drugs
atracurium
Beyond the preview
Go deeper on ACTRN12616001357448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001357448.